Elliott Greenleaf Awarded Healthcare/Life Sciences Deal of the Year by the M&A Advisor
Elliott Greenleaf, P.C. has been awarded the Healthcare/Life Sciences Deal of The Year (Under $500mm) by the M&A Advisor for the sale of Orexigen Therapeutics, Inc. Rafael Zahralddin and Eric Sutty, who served on behalf of the firm in this engagement, will be receiving the award on behalf of Elliott Greenleaf, P.C. at the M&A Advisor’s 13th Annual Turnaround Awards Gala on Thursday, March 28th at The Colony Hotel in Palm Beach, Florida.
The M&A Advisor’s host the 2019 Distressed Investing Summit which assembles the most active restructuring dealmakers, distressed asset investors, bankruptcy judges, advisors, consultants, and other key market experts – academics, media, government and political influencers, and celebrates the leading distressed M&A, restructuring, and refinancing transactions, product & services, firms and professionals in the United States and international markets. The Turnaround Awards, widely respected as a pinnacle of achievement, recognize excellence in deal making, accomplishments and the contributions of leading firms and professionals.
The M&A Advisor press release on this award is available at: https://news.thomasnet.com/companystory/elliott-greenleaf-p-c-announced-as-winner-of-the-13th-annual-turnaround-awards-40020830
If you would like to view Rafael X. Zahralddin’s full biography, please click here.
If you would like to view Eric Sutty’s full biography, please click here.